Astec LifeSciences enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,295	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.1	10.0	0.6	0.5	0.5
0.3	0.3	0.3	0.2	0.2
449	449	555	494	341
1,744	—	—	—	—
449	439	554	493	341
₹782.61	—	—	—	—

784	840	790	863	761
57.3%	53.5%	70.2%	57.2%	44.8%
0.26×	—	—	—	—

3.97×	—	—	—	—
−238.51×	—	—	—	—
−33.18×	—	—	—	—
439	448	381	458	628
−7.3	−4.5	−66.2	−5.9	76.3
−52.5	−49.4	−110	−42.2	42.6
—	−80.7	−8.4	10.2	74.7
−86.2	−86.2	−30.2	−125	−42.6
—	−86.3	−31.9	−131	−48.0
—	5.5	21.8	135	117

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals

₹ CrorePeersPUNJABCHEM MOL IPL INSECTICID DHARMAJ BHARATRAS ADVANCE HERANBAMcap ₹1,295 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,294.7
- Cash, Equiv & ST Investments	0.5	0.5	0.6	10.0	0.1
+ Minority Interest	0.2	0.2	0.3	0.3	0.3
+ Total Debt	341.2	493.9	554.5	448.9	448.9
Enterprise Value	—	—	—	—	1,743.8
Net Debt (memo)	340.7	493.4	554.0	438.9	448.8
EV per Share	—	—	—	—	782.61

Total Capital	760.7	863.4	789.6	839.8	784.0
Total Debt/Total Capital	44.85	57.20	70.23	53.45	57.26
Total Debt/EV	—	—	—	—	0.26

EV/Sales	—	—	—	—	3.97
EV/EBITDA	—	—	—	—	-238.51
EV/EBIT	—	—	—	—	-33.18
Reference Items — Trailing FY Values
Sales	628.2	458.2	381.3	448.1	438.9
EBITDA	76.3	-5.9	-66.2	-4.5	-7.3
EBIT	42.6	-42.2	-109.9	-49.4	-52.5
Operating Cash Flow	74.7	10.2	-8.4	-80.7	—
Free Cash Flow	-42.6	-125.3	-30.2	-86.2	-86.2
FCFF (free cash flow to the firm)	-48.0	-130.9	-31.9	-86.3	—
Capital Expenditure	117.3	135.5	21.8	5.5	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.